US 11,911,395 B2
Methods of treating obesity using antioxidant inflammation modulators
Colin J. Meyer, Southlake, TX (US); and Warren Huff, Dallas, TX (US)
Assigned to REATA PHARMACEUTICALS HOLDINGS, LLC, Plano, TX (US)
Filed by REATA PHARMACEUTICALS, INC., Irving, TX (US)
Filed on Sep. 13, 2018, as Appl. No. 16/130,242.
Application 16/130,242 is a continuation of application No. 13/085,338, filed on Apr. 12, 2011, granted, now 10,105,372.
Claims priority of provisional application 61/389,090, filed on Oct. 1, 2010.
Claims priority of provisional application 61/323,276, filed on Apr. 12, 2010.
Prior Publication US 2019/0076443 A1, Mar. 14, 2019
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 31/56 (2006.01)
CPC A61K 31/56 (2013.01) 26 Claims
 
1. A method of reducing the weight of a human patient that is overweight, comprising administering to the human patient a pharmaceutical composition, comprising an excipient and a compound of the formula:

OG Complex Work Unit Chemistry
wherein administration of the pharmaceutical composition reduces the overweight patient's weight, wherein the daily dose of said compound is from 1 mg to 50 mg.